EARNEST Partners’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-69
Closed -$4.63K – 524
2023
Q3
$4.63K Hold
69
– – ﹤0.01% 825
2023
Q2
$4.67K Hold
69
– – ﹤0.01% 821
2023
Q1
$3.73K Hold
69
– – ﹤0.01% 860
2022
Q4
$4.13K Hold
69
– – ﹤0.01% 841
2022
Q3
$3K Sell
69
-18
-21% -$900 ﹤0.01% 880
2022
Q2
$4K Hold
87
– – ﹤0.01% 834
2022
Q1
$5K Hold
87
– – ﹤0.01% 830
2021
Q4
$5K Hold
87
– – ﹤0.01% 844
2021
Q3
$5K Hold
87
– – ﹤0.01% 833
2021
Q2
$5K Hold
87
– – ﹤0.01% 847
2021
Q1
$6K Hold
87
– – ﹤0.01% 771
2020
Q4
$6K Hold
87
– – ﹤0.01% 751
2020
Q3
$4K Hold
87
– – ﹤0.01% 814
2020
Q2
$4K Hold
87
– – ﹤0.01% 777
2020
Q1
$4K Hold
87
– – ﹤0.01% 710
2019
Q4
$5K Hold
87
– – ﹤0.01% 772
2019
Q3
$4K Hold
87
– – ﹤0.01% 799
2019
Q2
$4K Hold
87
– – ﹤0.01% 813
2019
Q1
$4K Hold
87
– – ﹤0.01% 811
2018
Q4
$4K Buy
+87
New +$4.95K ﹤0.01% 766

Other funds holding EHC

EARNEST Partners's EHC Position: Q4 2023 in Review

EARNEST Partners sold out of Encompass Health (EHC) in Q4 2023, closing a stake of 69 shares — an estimated $4.63K sold.

EARNEST Partners first reported a position in EHC in Q4 2018 and held it in 20 quarters. The position peaked at $6K in Q1 2021. 435 funds tracked by Wall St. Rank hold EHC as of Q4 2023.

  • EARNEST Partners reported no remaining Encompass Health position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 69 Encompass Health shares in Q4 2023, an estimated $4.63K.
  • EARNEST Partners first reported a position in Encompass Health in Q4 2018 and held it in 20 quarters.
  • EARNEST Partners's Encompass Health position peaked at $6K in Q1 2021.
  • 435 funds tracked by Wall St. Rank held Encompass Health as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.